AFP is considered a marker of HCC differentiation and vascular invasion; thus, the measurement of its serum levels pre-LT has been proposed as a potential tool to identify HCC patients with a higher risk of tumor recurrence and poor post-LT survival who should be excluded from transplantation [48]. Here, AFP is linked to hepatocellular carcinoma.